A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"

A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"

<p>Abstract</p> <p>The International Society for the Biological Therapy of Cancer (iSBTc) has initiated in collaboration with the United States Food and Drug Administration (FDA) a programmatic look at innovative avenues for the identification of relevant parameters to assist clini...

Full description

Bibliographic Details
Main Authors: Schendel Dolores, Rivoltini Licia, Ribas Antoni, Potter Douglas M, Palucka A Karolina, Masucci Giuseppe, Malyguine Anatoli, Maecker Holden, Maio Michele, Maccalli Cristina, Kirkwood John M, Kleen Thomas O, Janetzki Sylvia, Håkansson Leif, Dhodapkar Madhav, Coukos George, Chaussabel Damien, Wigginton Jon, Wang Ena, Trinchieri Giorgio, Thurin Magdalena, Khleif Samir N, Lee Peter P, Fox Bernard A, Disis Mary L, Butterfield Lisa H, Seliger Barbara, Selvan Senthamil, Slingluff Craig L, Stroncek David F, Streicher Howard, Wu Xifeng, Zeskind Benjamin, Zhao Yingdong, Zocca Mai-Britt, Zwierzina Heinz, Marincola Francesco M
Format: Article
Language:English
Published: BMC 2008-12-01
Series:Journal of Translational Medicine
Online Access:http://www.translational-medicine.com/content/6/1/81

Internet

http://www.translational-medicine.com/content/6/1/81

Similar Items